Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months

Objectives. Bisphosphonates related osteonecrosis of the jaw (BRONJ) is a pathological condition characterized by bone exposure or latent infection in patients treated with the drug. The aim of the study is to monitor the BRONJ level of risk health in patients with cancer, according to a preventive...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparabombe, Scilla, Vitali, Lucia, Nori, Alessandra, Berlin, Ricarda Sara, Mazur, Marta, Orsini, Giovanna, Putignano, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167445/
https://www.ncbi.nlm.nih.gov/pubmed/25258628
http://dx.doi.org/10.1155/2014/475859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167445/
https://www.ncbi.nlm.nih.gov/pubmed/25258628
http://dx.doi.org/10.1155/2014/475859

Ejemplares similares